for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Halozyme Reports Q4 Earnings Per Share $0.85

Feb 20 (Reuters) - Halozyme Therapeutics Inc:

* HALOZYME REPORTS FOURTH QUARTER AND FULL-YEAR 2017 RESULTS

* Q4 EARNINGS PER SHARE $0.85

* Q4 REVENUE $189.6 MILLION VERSUS $39 MILLION

* REITERATED 2018 FINANCIAL GUIDANCE FOR NET REVENUE OF $115 MILLION TO $125 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up